![Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/18/2020.03.17.995738/F1.large.jpg)
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
![Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies - ScienceDirect Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721012146-fx1.jpg)
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies - ScienceDirect
![Cross-reactivity profiles of legumes and tree nuts using the xMAP® multiplex food allergen detection assay | Analytical and Bioanalytical Chemistry Cross-reactivity profiles of legumes and tree nuts using the xMAP® multiplex food allergen detection assay | Analytical and Bioanalytical Chemistry](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00216-017-0528-y/MediaObjects/216_2017_528_Figa_HTML.gif)
Cross-reactivity profiles of legumes and tree nuts using the xMAP® multiplex food allergen detection assay | Analytical and Bioanalytical Chemistry
![T‐cell cross‐reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors - Sioud - 2018 - Scandinavian Journal of Immunology - Wiley Online Library T‐cell cross‐reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors - Sioud - 2018 - Scandinavian Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ef5b53a8-419c-4b6d-95c9-9b4b62a3563d/sji12643-fig-0002-m.jpg)
T‐cell cross‐reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors - Sioud - 2018 - Scandinavian Journal of Immunology - Wiley Online Library
![Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection | Science Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection | Science](https://www.science.org/cms/10.1126/science.aaf8505/asset/9f11bfb5-c695-48e1-82be-141a8bb68957/assets/graphic/353_823_f1.jpeg)
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection | Science
![Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1367593113002317-gr1.jpg)
Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect
![WHO R&D Blueprint: novel Coronavirus: prospects for evaluating cross- reactivity of nCoV with SARS-CoV WHO R&D Blueprint: novel Coronavirus: prospects for evaluating cross- reactivity of nCoV with SARS-CoV](https://cdn.who.int/media/images/default-source/thumbnails-global/prospects-for-evaluating-cross-reactivity-of-ncov-with-sars-cov2c00696e-a00a-41a5-ba4e-2fcd7ba6eb93.tmb-479v.png?sfvrsn=b9e07497_2)
WHO R&D Blueprint: novel Coronavirus: prospects for evaluating cross- reactivity of nCoV with SARS-CoV
![Figures and data in Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay | eLife Figures and data in Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay | eLife](https://iiif.elifesciences.org/lax/79245%2Felife-79245-fig1-v1.tif/full/1500,/0/default.jpg)
Figures and data in Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay | eLife
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![SIDP on X: "@SIDPharm member @not_that_CDC and team found that implementation of a β-lactam cross-reactivity chart combined with enhanced #allergy assessment was associated with ⬆️ utilization of β-lactams in patients with PNA SIDP on X: "@SIDPharm member @not_that_CDC and team found that implementation of a β-lactam cross-reactivity chart combined with enhanced #allergy assessment was associated with ⬆️ utilization of β-lactams in patients with PNA](https://pbs.twimg.com/media/FEz67QrXMAsPHfB.jpg:large)
SIDP on X: "@SIDPharm member @not_that_CDC and team found that implementation of a β-lactam cross-reactivity chart combined with enhanced #allergy assessment was associated with ⬆️ utilization of β-lactams in patients with PNA
![Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K. Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.](https://journals.sagepub.com/cms/10.1177/0192623310382559/asset/images/large/10.1177_0192623310382559-fig3.jpeg)
Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.
![Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine](https://www.thelancet.com/cms/attachment/86769381-94ba-420c-91c9-6c2bb6aa8800/gr1_lrg.jpg)